Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Acitretin (Neotigason) 25mg Capsules {black_triangle}

Active Ingredient:
acitretin
Company:  
Teva UK Limited See contact details
ATC code: 
D05BB02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Acitretin Patient Alert Card

Alert card to be distributed to all patients (male and female) receiving acitretin each time the product is prescribed as a reminder of the required pregnancy prevention requirements/considerations.

{pdf_link}

Acitretin Pharmacist Checklist

{healthcare_pro_orange} For Healthcare Professionals

Guidance document for pharmacists including a background on the risks of acitretin in addition to a list of information to be confirmed with the patient prior to dispensing.

{pdf_link}

Acitretin Prescriber Checklist and Acknowledgement Form

{healthcare_pro_orange} For Healthcare Professionals

Checklist/acknowledgement form for use when prescribing acitretin to female patients. This is intended to support discussion with the patient, present the key principles of the PPP and record that discussions have taken place by recording patient and prescriber signatures.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Teva UK Limited
Company image
Address
Field House, Station Approach, Harlow, Essex, CM20 2FB
WWW
www.tevauk.com
Telephone
+44 (0)207 540 7000
Medical Information Direct Line
+44 (0)207 540 7117
Medical Information e-mail
[email protected]
Medical Information Fax
+44 (0) 207 000 1216
Stock Availability
0800 590 502